AstraZeneca PLC (AZN)

NYSE

$184.72

+$0.42

(+0.23%)

Pre-Market

AstraZeneca PLC (AZN) Live Price Chart

Last updated: ⁦2026-11-13 11:54:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

AstraZeneca PLC (AZN) operates in the -- sector and is listed on NYSE. The stock is currently priced at $184.72, with a market capitalization of $285.96B and a P/E ratio of 128.75. Over the past 52 weeks, its price has ranged from $153.41 to $212.71. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$285.96B
Open	$185.13
Day's High	$185.17
Day's Low	$184.70
Previous Close	$184.38
Volume	2.57K
Average Volume	3.01M
P/E Ratio	128.75
52-Week High	$212.71
52-Week Low	$153.41
Dividend Yield	1.24%
Earnings Date	12-31

AstraZeneca PLC (AZN) Pre-Market Stock Price

AstraZeneca PLC (AZN) is trading at $184.72 in pre-market trading as of 2026-11-13 11:53:00, up 0.18% ($0.34) from the previous close of $184.38

Pre-market trading shows how investors are pricing AZN before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

AstraZeneca PLC (AZN) 7-Day Stock Price Change

Over the past seven days, AstraZeneca PLC (AZN) moved from $186.85 to $184.72, representing a decline of 1.14% ($2.13).

The stock traded between $181.20 and $192.65 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 2.15 million shares, down versus the previous seven-day period, indicating lower trading activity.

AZN 52-Week Price Position

Position in Range: 52.8%

52W Low$153.41

52W High$212.71

AZN is currently trading at $184.72, placing it 52.8% of the way from its 52-week low of $153.41 to its 52-week high of $212.71. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is AstraZeneca PLC (AZN)?

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

AstraZeneca PLC Information

Employees	96,100
CEO	Pascal Claude Roland Soriot
Founded	1992
Exchange	NYSE
Company Website	https://www.astrazeneca.com

AZN Stock Events

View the latest dividend and stock split events for AstraZeneca PLC.

Dividend
Ex-Dividend Date	Aug 7, 2026
Payment Date	Sep 8, 2026
Dividend Per Share	$0.795

AZN News

Latest news related to AstraZeneca PLC and AZN stock.

Massive2026/11/12
BCMA Targeted Therapies Competitive Landscape Analysis: 100+ Pipeline Therapies Driving Innovation in Therapeutics Segment | DelveInsight
DelveInsight released a comprehensive competitive landscape report on BCMA-targeted therapies, analyzing 100+ pipeline drugs across 80+ companies. The report highlights recent clinical advances including Pfizer's positive Phase III results for ELREXFIO, AbbVie's BLA submission for etentamig, and Gilead's $7.8 billion acquisition of Arcellx to gain control of anito-cel. Key challenges include treatment resistance, relapse, and manufacturing complexity, while the pipeline focuses on improving durability, safety, and accessibility through next-generation approaches.
Read Full Article
Massive2026/11/11
GLP-1 RAs & Incretin-based Therapies Competitive Landscape Analysis: Key Developments by 200+ Companies Shaping the Treatment Landscape | DelveInsight
DelveInsight released a comprehensive competitive landscape report on GLP-1 receptor agonists and incretin-based therapies, covering 200+ pipeline drugs from 180+ active players. The report highlights approved drugs like MOUNJARO (tirzepatide) and OZEMPIC (semaglutide), with 30+ therapies in late-stage development and 60+ in mid/early stages. Key indications include obesity, type 2 diabetes, and cardiovascular outcomes. Recent developments include positive Phase III results for retatrutide, survodutide, and other dual/triple agonists from major pharmaceutical companies.
Read Full Article

Ways to Trade AZN at MEXC

AZN MEXC RealStocks

Own real AZN shares through MEXC's regulated brokerage partner.

Suitable for long-term holding.

Own the actual shares
Receive dividends and voting rights
Buy fractional shares starting at $1

AZN Tokenized Stocks

Get AZN price exposure through a blockchain-based token.

Suitable for trading outside U.S. market hours.

Token tracks the AZN price
Trade 24/7
Trade on weekends and holidays

AZN Stock Futures

Trade AZN price movements with futures contracts.

Suitable for short-term positions.

Go long or short
Trade 24/7
Up to 20x leverage

How to Buy AstraZeneca PLC (AZN) Stock on MEXC

Eligible investors can buy real shares of AstraZeneca PLC (AZN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AZN and Place Your Order

Open the RealStocks trading page and search for AZN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is AstraZeneca PLC (AZN) stock price today?

AstraZeneca PLC (AZN) is currently trading at $184.72, up 0.23% ($0.42) from the previous close of $184.38. Intraday prices update in real time during regular trading hours.

2.Is AZN stock going up or down today?

As of 2026-11-13 11:53:00, AZN is trading at $184.72, up 0.23% ($0.42) from its previous close of $184.38. The stock has traded between $184.70 and $185.17 during today’s regular session. Past price movements do not guarantee future results.

3.What is AZN pre-market price?

As of 2026-11-13 11:53:00, AZN is trading at $184.72 in pre-market trading, up 0.18% ($0.34) from the previous close of $184.38. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AZN after-hours price?

As of 2026-11-13 11:53:00, AZN is trading at $185.16 in after-hours trading, up 0.24% ($0.44) from the regular-session close of $184.72. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AZN stock trading now?

AZN trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AZN sit relative to its 52-week high and low?

Over the past 52 weeks, AZN has traded between a low of $153.41 and a high of $212.71. At $184.72, the stock is positioned 52.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is AstraZeneca PLC in?

AstraZeneca PLC (AZN) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is AstraZeneca PLC's market capitalization and where is it listed?

AstraZeneca PLC is listed on the NYSE exchange with a market capitalization of $285.96B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AZN valued in terms of P/E ratio and EPS?

AZN trades at a P/E ratio of 128.75, based on trailing-twelve-month EPS of $1.43. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does AstraZeneca PLC pay a dividend?

AstraZeneca PLC pays an indicated annual cash dividend of $2.29 per share, with a current dividend yield of 1.24% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as AstraZeneca PLC

PFE

MRK

JNJ

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top Gainers

Browse today's leading gainers in the US stock market

Modine Manufacturing Co

MOD

Newsmax, Inc.

NMAX

SES AI Corporation

SES

Ellington Credit Company

EARN

HawkEye 360, Inc.

HAWK

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to AZN, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Anthropic (PRE): Win NVIDIA H200

Claim PRE points for guaranteed prizes up to $3K

Search Stocks

Popular

MOD NMAX SES EARN HAWK

AZN Stock Calculator

Estimate the value between AZN shares and USD.

AZN Shares to USD

AZN Shares

AZN

USD

1.00 AZN shares = 184.717 USD

Calculations are estimates based on the latest available price and are for reference only.

AstraZeneca PLC (AZN)

Summary

Key Market Data

AstraZeneca PLC (AZN) Pre-Market Stock Price

AstraZeneca PLC (AZN) 7-Day Stock Price Change

AZN 52-Week Price Position

What is AstraZeneca PLC (AZN)?

AstraZeneca PLC Information

AZN Stock Events

AZN News

BCMA Targeted Therapies Competitive Landscape Analysis: 100+ Pipeline Therapies Driving Innovation in Therapeutics Segment | DelveInsight

GLP-1 RAs & Incretin-based Therapies Competitive Landscape Analysis: Key Developments by 200+ Companies Shaping the Treatment Landscape | DelveInsight

Ways to Trade AZN at MEXC

AZN MEXC RealStocks

AZN Tokenized Stocks

AZN Stock Futures

How to Buy AstraZeneca PLC (AZN) Stock on MEXC

Frequently Asked Questions (FAQ)

Explore More US Stocks

Stocks in the Same Sector

Largest Market Cap

Most Actively Traded

Top Gainers

Top 5 Cryptocurrencies

Compliance Disclosure and Data Source

Disclaimer

Search Stocks

AZN Stock Calculator